Dennis Ding

Stock Analyst at Jefferies

(0)
# 4854
Out of 5,333 analysts
18
Total ratings
14.29%
Success rate
-26.05%
Average return
Main Sectors:
Top Industries:
15 Stocks
Name Action PT Current % Upside Ratings Updated
CRNX Crinetics Pharmaceut...
Upgrades: Buy
55
30.7 79.15% 1 Jan 22, 2025
IKT Inhibikase Therapeut...
Initiates Coverage On: Buy
8
2 300% 1 Nov 8, 2024
ASMB Assembly Biosciences
Upgrades: Buy
2 35
12.18 187.36% 1 Sep 20, 2024
FOLD Amicus Therapeutics
Initiates Coverage On: Buy
18
6 200% 1 Sep 6, 2024
ABUS Arbutus Biopharma
Maintains: Strong Buy
5 7
3.23 116.72% 2 Sep 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
8 6
4.32 38.89% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 1
0.1 400% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
648
n/a n/a 1 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 22
70.27 -68.69% 1 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
18.4 30.43% 1 Dec 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Jan 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
195 52
n/a n/a 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
10.64 -6.02% 1 Oct 26, 2021